Advances in Biomarker Testing and Targeted Therapies in NSCLC
home / peer-exchange / advances-in-biomarker-testing-and-targeted-therapies-in-nsclc
A panel of expert oncologists have a detailed discussion on emerging biomarkers, molecular testing strategies, and the evolving targeted treatment landscape in non–small cell lung cancer.